Results 231 to 240 of about 211,122 (354)
Quality of Life After Surgical Treatment of Head and Neck Paragangliomas
ABSTRACT Background Head and neck paragangliomas (HNPGLs) are rare neuroendocrine tumors and often arise in the head and neck. Due to their localization, the tumor and its surgical treatment pose a risk for cranial nerve impairments. Few studies have focused on the health‐related quality of life (HRQOL) in patients with HNPGLs and their relation to ...
Christina Sauter +5 more
wiley +1 more source
Occupational Allergic Contact Dermatitis to Ethylhexylglycerin in an Alcohol-Based Hand Disinfectant. [PDF]
Brans R, Skudlik C.
europepmc +1 more source
Severe Acute Allergic Contact Dermatitis Presenting as Erythroderma: A Case Report
Burçin Beken +3 more
openalex +1 more source
New aspects of the Slug Mucosal Irritation assay: predicting nasal stinging, itching and burning sensations [PDF]
Adam +52 more
core +1 more source
ABSTRACT Background The microvascular bone free flap (MBFF) is the preferred reconstruction after mandibular resection as it facilitates secondary dental rehabilitation. Methods In this multicenter study, patients were included if treated between January 2017 and January 2022 for head and neck cancer with MBFF reconstruction.
Lise‐Marie Roussel +11 more
wiley +1 more source
Requirements for Alternative In Vitro and In Silico Skin Models of Irritant and Allergic Contact Dermatitis. [PDF]
Portugal-Cohen M +9 more
europepmc +1 more source
Knowledge about occupational latex allergy amongst Thai nurses and student nurses. [PDF]
De Vocht, Frank +2 more
core +1 more source
ABSTRACT Background To evaluate postoperative health‐related quality of life (HRQoL) for pituitary adenoma patients, multidimensional assessment is important. Available data is limited on long‐term follow‐up. Methods Prospectively, 52 nonfunctioning (NFA) and functioning (FA) pituitary adenoma patients were included.
Gonneke E. Joustra +7 more
wiley +1 more source
Not Just Pink Eye: Allergic Contact Dermatitis to Alcaftadine 0.25% Ophthalmic Solution. [PDF]
Betancourt Ponce M, Reeder M.
europepmc +1 more source

